К содержанию
РецензированоEN2020

The Application Of Preparation Mavix In The Complex Treatment Of Ischemic Stroke In The Elderly Age

Asadullayev Maksud Makhmudovich · Rakhimbayeva Gulnara Sattarovna (Professor Of Neurology Department Of Tashkent Medical Academy, Uzbekistan) · Vakhabova Nargiza Maksudovna (Professor Of Neurology, Tashkent Medical Academy, Uzbekistan) · Asadullaev Khomidkhon Maksudovich (terms of the creative Assistant Of The Department Of Neurology, Tashkent Medical Academy, Uzbekistan)

The American Journal of Medical Sciences and Pharmaceutical Research · 02 · 2 —3 · 2020

Аннотация

Based on the results of clinical and neurological studies, the use of mavix in the complex treatment of elderly patients with ischemic stroke is justified. The obtained data on the differentiation of the therapeutic response contribute to the optimization of therapy for acute ischemic stroke in order to stop or slow down its progression and maintain the quality of life of both the patients themselves and their families. KEYWORDS Ischemic stroke, elderly patients, treatment, neurocytoprotector, mavix.

Доказательный фрагмент

«Based on the results of clinical and neurological studies, the use of mavix in the complex treatment of elderly patients with ischemic stroke is justified.»

Образец извлечения

Демо-превью

Based on the results of clinical and neurological studies, the use of mavix in the complex treatment of elderly patients with ischemic stroke is justified. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.

Цитирований
0
Тип
Журнал
Страна
Узбекистан
Ключевые слова
Ischemic stroke, elderly patients, treatment, neurocytoprotector, mavix
Открыть DOI
Спросить CiteX об этой работе

Смежные источники